Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT06920056
PHASE1

A Study of BGM0504 in Overweight or Obese Participants

Sponsor: BrightGene Bio-Medical Technology Co., Ltd.

View on ClinicalTrials.gov

Summary

The purpose of the study is to evaluate the influence of BGM0504 injection on gastric emptying and Pharmacokinetics of metformin and warfarin in overweight or obese participants

Official title: A Single Center, Open-label, Fixed Sequence Trial, Investigating the Influence of BGM0504 Injection on Gastric Emptying and Pharmacokinetics of Metformin and Warfarin in Overweight or Obese Participants

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

28

Start Date

2025-03-25

Completion Date

2025-07-25

Last Updated

2026-10-13

Healthy Volunteers

No

Interventions

DRUG

Paracetamol

oral, postprandial

DRUG

Metformin Hydrochloride

Oral , Fasting

DRUG

Warfarin

Oral , Fasting

DRUG

BGM0504

Administered SC

Locations (1)

The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine (Yunnan Provincial Hospital of Traditional Chinese Medicine)

Kunming, Yunnan, China